Clinical trial
An Open-Label, Single-Group Study to Evaluate the Efficacy and Safety of SPN-820 in Adults With Major Depressive Disorder
NCT06235905 is registered in ClinicalTrials.gov with Navitor Pharmaceuticals, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Open-Label, Single-Group Study to Evaluate the Efficacy and Safety of SPN-820 in Adults With Major Depressive Disorder
- Lead sponsor
- Navitor Pharmaceuticals, Inc.
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- February 15, 2024
- Completion date
- August 18, 2024
- Enrollment
- 40 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.